Daiichi Sankyo
Simon King is an accomplished human resources executive currently serving as Chief People Officer at Daiichi Sankyo, Inc. since August 2019. Prior to this role, Simon was the Chairman of the Board for HR People + Strategy at the SHRM Executive Network from January 2018 to December 2019, contributing to the development of leading conferences and best practices in the HR profession. Simon has extensive experience in global talent management, having held leadership positions at Bristol-Myers Squibb and AstraZeneca, where responsibilities included overseeing large HR teams and implementing comprehensive talent strategies across diverse regions. Simon's career began at ICI Pharmaceuticals and Zeneca Pharmaceuticals, showcasing a long-standing commitment to enhancing human resources functions throughout the pharmaceutical industry. Academic credentials include a BSc in Biological Sciences from The University of Edinburgh.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.